HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
July 01, 2024 16:31 ET
|
HOOKIPA Pharma Inc.
Novel arenaviral therapeutic vaccine, developed in collaboration with Gilead Sciences, Inc. (Gilead), to be evaluated as a potential component of a curative regimen for human immunodeficiency...
bioLytical Donates 1200 HIV Testing Kits Across the United States to Support National HIV Testing Day
June 27, 2024 09:00 ET
|
bioLytical Laboratories Inc.
bioLytical helps boost testing with free HIV rapid test donations to KFF and the Greater Than HIV campaign to support national testing efforts
Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system
May 29, 2024 06:30 ET
|
Casey House
TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – a hospital unlike any other providing care to those living with and at risk of HIV – today announces the launch of its latest advocacy campaign,...
National Implementation of Supportive Housing Initiative to Close the Gap on HIV-Related Inequities Outlined in the National HIV/AIDS Strategy
May 07, 2024 09:00 ET
|
Corporation for Supportive Housing
Boston, Massachusetts, May 07, 2024 (GLOBE NEWSWIRE) -- The Center for Innovation in Social Work and Health (CISWH) at the Boston University School of Social Work (BUSSW) and CSH (Corporation for...
Immunocore presented two posters at CROI 2024
March 05, 2024 16:30 ET
|
Immunocore Holdings Limited
Immunocore presented two posters at CROI 2024 Preclinical data highlights importance of TCR biology in development of new HIV treatments (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. &...
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
January 05, 2024 07:00 ET
|
Immunocore Holdings Limited
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation Increasing commercial access to KIMMTRAK (tebentafusp-tebn)...
New Novotech Report Finds 1,000 HIV Clinical Trials Globally
December 28, 2023 21:49 ET
|
Novotech
Novotech today released the latest 2023 global clinical trial landscape report on HIV, a condition now affecting more than 39 million people.
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
December 21, 2023 07:01 ET
|
HOOKIPA Pharma Inc.
Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per shareFollowing the close of the transaction on December 20, 2023, Gilead holds 19.4% of HOOKIPA’s outstanding...
Theratechnologies annonce l’approbation par la FDA de l’administration par injection IV directe d’une durée de 90 secondes de la dose de charge de Trogarzoᴹᴰ
December 13, 2023 07:30 ET
|
Theratechnologies
La mise à jour de la monographie signifie que les nouveaux patients à qui l’on prescrit TrogarzoMD n’ont plus besoin de commencer le traitement par une perfusion de 30 minutesL’injection IV directe...
Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose
December 13, 2023 07:30 ET
|
Theratechnologies
Updated label means new Trogarzo® patients no longer require initiation of treatment by 30-minute infusionComplete IV push method enables easier and more convenient administration of Trogarzo® for...